Practice and Progress in Cardiac Pacing and Electrophysiology

Foreword.- Preface.- List of Contributors.- One: Arrhythmias and Antiarrhythmic Treatment strategies.- 1. Endpoints and trials: a matter of life and death. Classification of death in patients under antiarrhythmic treatment.- 2. The role of transient ischaemia in the pathophysiology of ventricular arrhythmias in patients with coronary artery disease.- 3. Sudden death and tachyarrhythmias in athletes.- 4. The evaluation of antiarrhythmics.- 5. Atrial fibrillation: maintaining the sinus rhythm.- 6. Arrhythmogenic right ventricular dysplasia.- Two: Non-Invasive Electrocardiology.- 7. Signal averaged electrocardiogram. Current applications and limitations.- 8. Can analysis of heart rate variability predict arrhythmias and antiarrhythmic effects?.- 9. QT dispersion.- 10. Use of baroreceptor reflex sensitivity in the prediction of risk after myocardial infarction.- 11. Ambulatory monitoring of T-wave alternans for detection of cardiac electrical instability: scientific rationale and technical considerations.- Three: Cardiac Pacing.- 12. The state of electrical cardiac stimulation — 1995.- 13. Long-term rate adaptive atrial (AAIR) pacing: is it feasible?.- 14. Single lead atrial synchronised ventricular (VDD) pacing.- 15. Benefits of sensor driven dual chamber pacing.- 16. Cardiopulmonary evaluation of patients with rate responsive pacemakers.- 17. Programming the upper rate behaviour and the atrial escape interval in paced patients with unstable atrium.- 18. Automatic mode switching in DDDR pacemakers.- 19. Pacing to prevent arrhythmias: bradycardia/tachycardia syndrome.- 20. Managing paroxysmal atrial tachycardias in patients with pacemakers.- 21. Pacing to prevent atrial fibrillation.- 22. The paradigm shift: pacing to prevent arrhythmias. Ventricular tachycardia.- 23. Howmay dilated cardiomyopathy benefit from cardiac pacing?.- 24. Various methods of monitoring the autonomic nervous system using the pacing lead as a sensor. Clinical results and prospectives.- 25. Rationale for the management of pacemaker and defibrillator complications.- Four: Radiofrequency Ablation of Arrhythmias.- 26. Radiofrequency ablation of atrial flutter.- 27. The spectrum of “Mahaim-like” accessory connections and their associated ablation techniques.- 28. New approaches to ablation of left-sided and posteroseptal accessory pathways.- 29. Advances in transcatheter endocardial mapping and radiofrequency ablation of ventricular arrhythmias.- 30. Catheter ablation of ventricular tachycardia in patients with coronary heart disease.- Five: Implantable Cardioverter-Defibrillators.- 31. Internal atrial defibrillation and implantable atrial defibrillators.- 32. The cardiologist’s dilemma: drugs or ICDs in patients with severe ventricular dysfunction.- 33. Can pump failure in ICD patients with low ejection fraction be avoided by adding new pacing modes to current ICD’s?.- 34. Long-term outcome with transvenous (-subcutaneous) defibrillation leads.- 35. Insights into ventricular tachycardia onset mechanism from analysis of stored ICD electrograms.- 36. Managing the problem of atrial tachyarrhythmias in patients with ICD’s.- 37. Technological advances in implantable cardioverter defibrillator leads and waveforms: paving the way for smaller ICDs.- 38. Driving restrictions after cardioverter/defibrillator implantation.- 39. Arrhythmias, implantable devices and driving “The United Kingdom Advisory Panel Experience”.